Monocyte Chemoattractant Protein-Induced Protein 1 Targets Hypoxia-Inducible Factor 1α to Protect Against Hepatic Ischemia/Reperfusion Injury.
Peng SunYue-Xin LuDaqing ChengKuo ZhangJilin ZhengYupeng LiuXiaozhan WangYu-Feng YuanYi-Da TangPublished in: Hepatology (Baltimore, Md.) (2018)
Sterile inflammation is an essential factor causing hepatic ischemia/reperfusion (I/R) injury. As a critical regulator of inflammation, the role of monocyte chemoattractant protein-induced protein 1 (MCPIP1) in hepatic I/R injury remains undetermined. In this study, we discovered that MCPIP1 downregulation was associated with hepatic I/R injury in liver transplant patients and a mouse model. Hepatocyte-specific Mcpip1 gene knockout and transgenic mice demonstrated that MCPIP1 functions to ameliorate liver damage, reduce inflammation, prevent cell death, and promote regeneration. A mechanistic study revealed that MCPIP1 interacted with and maintained hypoxia-inducible factor 1α (HIF-1α) expression by deubiquitinating HIF-1α. Notably, the HIF-1α inhibitor reversed the protective effect of MCPIP1, whereas the HIF-1α activator compensated for the detrimental effect of MCPIP1 deficiency. Thus, we identified the MCPIP1-HIF-1α axis as a critical pathway that may be a good target for intervention in hepatic I/R injury. (Hepatology 2018; 00:000-000).
Keyphrases
- oxidative stress
- endothelial cells
- high glucose
- ischemia reperfusion injury
- cell death
- diabetic rats
- mouse model
- protein protein
- binding protein
- amino acid
- stem cells
- randomized controlled trial
- end stage renal disease
- dendritic cells
- drug induced
- cell proliferation
- chronic kidney disease
- liver injury
- gene expression
- genome wide
- prognostic factors
- stress induced